|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-3-11
|
|
pubmed:abstractText |
Because of the increasing number of long-term survivors of metastatic testicular germ-cell cancer, a general concern has been secondary morbidities, especially cardiovascular risk factors.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
229-36
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:11885999-Adolescent,
pubmed-meshheading:11885999-Adult,
pubmed-meshheading:11885999-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11885999-Blood Pressure,
pubmed-meshheading:11885999-Cisplatin,
pubmed-meshheading:11885999-Fertility,
pubmed-meshheading:11885999-Follicle Stimulating Hormone,
pubmed-meshheading:11885999-Hearing,
pubmed-meshheading:11885999-Heart,
pubmed-meshheading:11885999-Humans,
pubmed-meshheading:11885999-Luteinizing Hormone,
pubmed-meshheading:11885999-Male,
pubmed-meshheading:11885999-Middle Aged,
pubmed-meshheading:11885999-Peripheral Nervous System Diseases,
pubmed-meshheading:11885999-Testicular Neoplasms
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.
|
|
pubmed:affiliation |
Department of Internal Medicine (Cancer Research), West German Cancer Center, University of Essen. dirk.strumberg@uni-essen.de
|
|
pubmed:publicationType |
Journal Article
|
